Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1031P (RNA, U6 small nuclear 1031, pseudogene) is classified as a pseudogene related to the U6 small nuclear RNA gene family[5][1]. Unlike functional U6 small nuclear RNAs, which participate in the spliceosome complex and are required for mRNA splicing in eukaryotes[6], pseudogenes like RNU6-1031P are generally non-functional genomic sequences derived from ancestral genes. There is no evidence this pseudogene encodes a functional RNA molecule or protein, nor is it recognized or studied as a therapeutic target, biomarker, or drug interactor in biomedical research[5][1][2]. The entry is not associated with a role in disease or therapeutic intervention, and lacks evidence for molecular or clinical relevance. If your objective is to identify actionable targets, this entity should be considered incorrect for those purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1031, pseudogene (RNU6-1031P).